Access cutting-edge clinical high risk for psychosis (chr) treatment through this clinical trial at a research site in Irvine. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Irvine location
Preparing your pre-screening questions…
Access clinical high risk for psychosis (chr) specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related clinical high risk for psychosis (chr) treatment provided free
Check if you qualify for this clinical high risk for psychosis (chr) clinical trial in Irvine, CA
No-Cost Study Care
Local to Irvine
Convenient for CA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The goal of this clinical trial is to learn how tests undertaken by people at high risk of developing psychosis (aged 17 to 30 years old) change when those people are given the study drug MT1988 daily for 8 weeks. This will help identify tests that could be used in later trials developing treatments for symptoms in people at high risk of developing psychosis, to measure whether those new treatments are effective. The main question this trial aims to answer is: Can any of the tests (biomarkers) used in this study detect changes in participants dosed with one of two different dose levels of MT1988? Researchers will compare the results from two dose levels of MT1988 to a placebo group. Researchers do not expect to see the test results change in participants taking placebo and this will be compared to changes expected in test results in participants taking MT1988. Participants will: * take a dose of MT1988 or placebo twice per day for 8 weeks * attend clinic appointments every two weeks to undertake assessments * report any side effects they experience to the researchers
Sponsor: Monument Therapeutics Limited
Yes, this clinical trial (NCT07226895) has an active research site in Irvine, CA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for clinical high risk for psychosis (chr) treatment options in Irvine, CA, this clinical trial (NCT07226895) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Irvine research site is actively enrolling participants for this clinical trial. You'll receive care from experienced clinical high risk for psychosis (chr) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all clinical high risk for psychosis (chr) clinical trials near you to find additional studies recruiting in your area.
See all schizophrenia clinical trials recruiting in Irvine — not just this study.
Browse Schizophrenia Trials in Irvine →